MDSS EUROPEAN AUTHORIZED REPRESENTATIVE SERVICES MDSS CONSULTING   ENGLISH    GERMAN    CHINESE
News Updates
  • Looking for a suitable GMDN-Code?
    MDSS can assist you to determine an appropriate code for your products!
    more


  • MDSS, may support you with the process of applying for a Certificate of Marketability...more


  • 23.03.2017
    7. Medical Device Networking Meeting
    Ulm


  • 27.04.2017
    8. Medical Device Networking Meeting
    Hanover


    
HIGHLIGHTS
In-House Workshops
The "NEW CE" mark
Book now!
to make sure you’re ready to survive and thrive!


New Medical Device Regulation (MDR) in Europe

Are you ready for the changes?


We are pleased to help you!
(Read more)



CONTACT

MDSS GmbH
Schiffgraben 41
30175 Hannover
Germany

Phone
(+49)-511-6262 8630
FAX
(+49) -511-6262 8633

Click here to
contact us





MDSS Consulting & Training

Consulting Services for the European Union

consulting  for the European UnionThe health care policy in European countries has attracted greater public interest over the last years.  The demand for a healthy life and increasing prevention as well as adequate medical care in the event of an accident or illness increase the demand for innovative medic al devices.  Within the framework of these changes the requirements which are bestowed upon medical device manufacturers have become more specified.

The Medical Devices Directives (90/385/EEC, 93/42/EEC, 98/79/EC) and their implementation into national law (medical device law and decrees) have been revised several times and have been the basis for the marketing of medical devices in Europe.  The scope of existing guidance documents for the implementation of guidelines  (MEDDEV) and harmonized standards  are permanently being  concretized and extended.  Medical device manufacturers have to fix their view firmly on new and / or changed requirements.

In the US, access to the market is determined by FDA requirements for medical devices. For decades the so-called Premarket Approval 'PMA' and Premarket Notification '510(k)' procedures have been the determining factors for registration in the U.S. The PMA path has always been obligatory for innovative products; the 'De Novo' procedure, introduced 1997 and little used for a long time, offers a possible shortened market access for such products as well.

 


The consultancy team of MDSS offers many years of experience in  the interpretation and implementation of regulatory requirements.  Through our consultation services we guarantee the secure handling of the following issues: